1 "Urinary Bladder" clinical trial found.
-
A Phase 1a/1b Study of LY4052031 an Antibody-Drug Conjugate Targeting Nectin-4 in Participants with Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors
This is a Phase 1a/1b study testing a new drug called LY4052031 (an experimental cancer drug) in patients with advanced cancers, including bladder (urothelial ...
Phase
Interventional
